
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Antibiotics from McKnight's Long Term Care News</title>
        <link>http://www.mcknights.com/antibiotics/topic/9772/</link>
        <description>Articles tagged with Antibiotics from McKnight's Long Term Care News</description>
        <itunes:author>McKnight's</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>custserv@mcknights.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/45/MCK_Mobile_logo_44402.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Stomach acid drugs raise risk of C. diff</title>
          <description>Stomach acid is often treated with medications such as Pepcid, but that could put long-term care residents or hospitalized patients at risk for Clostridium difficile, according to a new analysis.</description>
          <link>http://www.mcknights.com/stomach-acid-drugs-raise-risk-of-c-diff/article/291271/</link>
          <pubDate>Wed, 01 May 2013 19:00:00 GMT</pubDate>
          <itunes:summary>Stomach acid is often treated with medications such as Pepcid, but that could put long-term care residents or hospitalized patients at risk for Clostridium difficile, according to a new analysis.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>Limiting use of common antihistamines could reduce C. diff in facilities, researchers say</title>
          <description>Taking antihistamines such as Tagamet, Pepcid and Zantac increases the risk that people in healthcare settings will be infected with Clostridium difficile, according to a recently published study.</description>
          <link>http://www.mcknights.com/limiting-use-of-common-antihistamines-could-reduce-c-diff-in-facilities-researchers-say/article/286579/</link>
          <pubDate>Fri, 29 Mar 2013 10:30:00 GMT</pubDate>
          <itunes:summary>Taking antihistamines such as Tagamet, Pepcid and Zantac increases the risk that people in healthcare settings will be infected with Clostridium difficile, according to a recently published study.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>&apos;Fake stool&apos; a possible aid for C. diff patients</title>
          <description>A pair of Clostridium difficile patients were cured through introduction of a super-probiotic synthetic stool called RePOOPulate, leading researchers to express hope that the treatment can be adopted on a more widespread basis.</description>
          <link>http://www.mcknights.com/fake-stool-a-possible-aid-for-c-diff-patients/article/275494/</link>
          <pubDate>Thu, 10 Jan 2013 11:30:00 GMT</pubDate>
          <itunes:summary>A pair of Clostridium difficile patients were cured through introduction of a super-probiotic synthetic stool called RePOOPulate, leading researchers to express hope that the treatment can be adopted on a more widespread basis.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>Bloodstream infection test wins FDA approval</title>
          <description>The Food and Drug Administration approved a test Wednesday that can help physicians diagnose an infection and select the proper antibiotic much more rapidly than with existing tests.</description>
          <link>http://www.mcknights.com/bloodstream-infection-test-wins-fda-approval/article/248199/</link>
          <pubDate>Fri, 29 Jun 2012 19:29:26 GMT</pubDate>
          <itunes:summary>The Food and Drug Administration approved a test Wednesday that can help physicians diagnose an infection and select the proper antibiotic much more rapidly than with existing tests.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>Antacids linked to higher risk of c. diff, study finds</title>
          <description>Use of proton pump inhibitors, which have medications used to suppress stomach acid, can increase the risk of Clostridium difficile infections, especially when combined with antibiotics, a new study finds.</description>
          <link>http://www.mcknights.com/antacids-linked-to-higher-risk-of-c-diff-study-finds/article/241626/</link>
          <pubDate>Thu, 17 May 2012 17:00:00 GMT</pubDate>
          <itunes:summary>Use of proton pump inhibitors, which have medications used to suppress stomach acid, can increase the risk of Clostridium difficile infections, especially when combined with antibiotics, a new study finds.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>Combining blood pressure drugs with antibiotics could be risky for seniors, study says</title>
          <description>Older adults who take blood pressure drugs called calcium channel blockers could experience severe drops in blood pressure if also given antibiotics such as erythromycin (brands like E-Mycin) or clarithromycin (Biaxin), according to a new study. It is believed to be the first large-scale examination of the potential of severe low blood pressure among individuals taking these drugs simultaneously.</description>
          <link>http://www.mcknights.com/combining-blood-pressure-drugs-with-antibiotics-could-be-risky-for-seniors-study-says/article/194465/</link>
          <pubDate>Wed, 19 Jan 2011 11:30:00 GMT</pubDate>
          <itunes:summary>Older adults who take blood pressure drugs called calcium channel blockers could experience severe drops in blood pressure if also given antibiotics such as erythromycin (brands like E-Mycin) or clarithromycin (Biaxin), according to a new study. It is believed to be the first large-scale examination of the potential of severe low blood pressure among individuals taking these drugs simultaneously.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
        <item>
          <title>Source of a MRSA defense? Scientists find powerful antibiotics on frog skins</title>
          <description>Their wart-causing powers having long since been debunked, frogs are now getting a chance to prove their medical worthiness, according to new reports. Scientists are now using frog skin to produce new antibiotics to fight antibiotic-resistant superbugs such as MRSA.</description>
          <link>http://www.mcknights.com/source-of-a-mrsa-defense-scientists-find-powerful-antibiotics-on-frog-skins/article/177637/</link>
          <pubDate>Fri, 27 Aug 2010 10:30:00 GMT</pubDate>
          <itunes:summary>Their wart-causing powers having long since been debunked, frogs are now getting a chance to prove their medical worthiness, according to new reports. Scientists are now using frog skin to produce new antibiotics to fight antibiotic-resistant superbugs such as MRSA.</itunes:summary>
          <itunes:author>McKnight's</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  